Arvinas Cost Of Revenue from 2010 to 2024

ARVN Stock  USD 25.86  0.75  2.99%   
Arvinas Cost Of Revenue yearly trend continues to be very stable with very little volatility. Cost Of Revenue is likely to grow to about 10.1 M this year. During the period from 2010 to 2024, Arvinas Cost Of Revenue quarterly data regression pattern had sample variance of 94.5 T and median of  22,876,000. View All Fundamentals
 
Cost Of Revenue  
First Reported
2016-12-31
Previous Quarter
1.7 M
Current Value
1.7 M
Quarterly Volatility
7.3 M
 
Covid
Check Arvinas financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arvinas' main balance sheet or income statement drivers, such as Tax Provision of 5.7 M, Net Interest Income of 33.9 M or Interest Income of 33.9 M, as well as many indicators such as Price To Sales Ratio of 41.18, Dividend Yield of 0.0 or PTB Ratio of 3.29. Arvinas financial statements analysis is a perfect complement when working with Arvinas Valuation or Volatility modules.
  
Check out the analysis of Arvinas Correlation against competitors.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.

Latest Arvinas' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Arvinas over the last few years. Cost of Revenue is found on Arvinas income statement and represents the costs associated with goods and services Arvinas provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Arvinas' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arvinas' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Arvinas Cost Of Revenue Regression Statistics

Arithmetic Mean15,675,093
Geometric Mean0.00
Coefficient Of Variation62.02
Mean Deviation8,896,434
Median22,876,000
Standard Deviation9,721,948
Sample Variance94.5T
Range32M
R-Value(0.71)
Mean Square Error49.9T
R-Squared0.51
Significance0
Slope(1,552,183)
Total Sum of Squares1323.2T

Arvinas Cost Of Revenue History

202410.1 M
20236.7 M
20228.2 M
2019M
2018null
201732 M

About Arvinas Financial Statements

Arvinas investors utilize fundamental indicators, such as Cost Of Revenue, to predict how Arvinas Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue6.7 M10.1 M

Pair Trading with Arvinas

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arvinas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will appreciate offsetting losses from the drop in the long position's value.

Moving against Arvinas Stock

  0.32FBRX Forte Biosciences TrendingPairCorr
  0.31CINGW Cingulate WarrantsPairCorr
The ability to find closely correlated positions to Arvinas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arvinas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arvinas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arvinas to buy it.
The correlation of Arvinas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arvinas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arvinas moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arvinas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock:
Check out the analysis of Arvinas Correlation against competitors.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.79)
Revenue Per Share
2.327
Quarterly Revenue Growth
1.96
Return On Assets
(0.20)
Return On Equity
(0.59)
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.